Expanding the Universal Medication Schedule: a patient-centred approach by Bailey, Stacy Cooper et al.
Expanding the Universal Medication
Schedule: a patient-centred approach
Stacy Cooper Bailey,1 Michael S Wolf,2 Andrea Lopez,3 Allison Russell,2
Alice Hm Chen,3 Dean Schillinger,3 Glen Moy,4 Urmimala Sarkar3
To cite: Bailey SC, Wolf MS,
Lopez A, et al. Expanding the
Universal Medication
Schedule: a patient-centred
approach. BMJ Open 2014;4:
e003699. doi:10.1136/
bmjopen-2013-003699
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2013-003699).
Received 31 July 2013
Revised 21 October 2013
Accepted 7 November 2013
1Division of Pharmaceutical
Outcomes and Policy, UNC
Eshelman School of
Pharmacy, Chapel Hill, North
Carolina, USA
2Division of General Internal





Population at San Francisco
General Hospital and Trauma










Dr Stacy Cooper Bailey;
scbailey@unc.edu
ABSTRACT
Objective: Improved drug labelling for chronic pill-
form medications has been shown to promote patient
comprehension, adherence and safety. We extended
health literacy principles and included patients’
perspectives to improve instructions for: (1) non-pill
form, (2) short term, (3) ‘as needed,’ (4) tapered and
(5) escalating dose medications.
Setting: Participants were recruited via convenience
sampling from primary care clinics in Chicago, Illinois
and San Francisco, California, USA.
Participants: 40 adult, English-speaking participants
who reported taking at least one prescription drug in
the past 12 months were enrolled in the study.
Primary and secondary outcomes: Participant
opinions, preferences and comprehension of standard
and improved medication instructions were assessed
during four iterative waves of discussion groups. Brief
interviews preceding the discussion groups measured
individuals’ literacy skills, sociodemographic and health
characteristics.
Results: On average, participants were 46 years old,
took four medications and reported two chronic health
conditions. Patients varied sociodemographically; 40%
were men and 33% had limited literacy skills. Patients
agreed on the need for simpler terminology and
specificity in instructions. Discussions addressed
optimal ways of presenting numeric information,
indication and duration of use information to promote
comprehension and safe medication use. Consensus
was reached on how to improve most of the
instructions.
Conclusions: Through this patient-centred approach,
we developed a set of health literacy-informed
instructions for more challenging medications.
Findings can inform current drug labelling
initiatives and promote safe and appropriate
medication use.
INTRODUCTION
Approximately 4.5 million outpatient visits
each year are related to adverse drug events
(ADEs) and recent estimates indicate that
preventable, outpatient ADEs cost the US
healthcare system more than US$8 billion/
year.1–4 While the underlying factors leading
to outpatient medication errors vary,
patient’s misunderstanding of prescription
(Rx) medication instructions is likely to be a
major root cause.2 5 6 This is not surprising,
as current Rx labelling practices frequently
fail to support patient’s understanding or
safe use of prescribed drugs. Evidence indi-
cates that Rx labelling is highly variable and
Rx instructions are often vague and unneces-
sarily complex.7 8 As a result, patients may
misinterpret seemingly simple directions for
use. A 2006 study found that nearly half
(46%) of patients misinterpreted at least one
of five common Rx instructions.9
In response to this patient safety and health-
care quality concern, the 2008 Institute of
Medicine (IOM) report Standardizing
Medication Labels called for setting labelling
standards to help patients easily understand
Rx directions for use.10 The ‘Universal
Medication Schedule’ (UMS) was proposed in
this report to promote safe medication use.
The UMS uses ‘best practices’ from the fields
of health literacy, medicine and education to
explicitly describe how to take daily use, pill-
form medications.10 Specifically, the UMS
grounds medication-taking to four time
periods (morning, noon, evening, bedtime)
and uses simplified language and formatting
to promote understanding (ie, ‘take 1 pill in
the morning and 1 pill at bedtime’ instead of
‘take one tablet twice daily’). An efficacy trial
of the UMS instructions found that patients
were 33% more likely to correctly interpret
Strengths and limitations of this study
▪ This study was conducted in two distinct geo-
graphical regions, incorporated diverse view-
points and used health literacy ‘best practices’ to
improve drug labelling.
▪ While rigorous, our study relied upon a relatively
small sample of English-speaking adults and
focused only on developmental activities.
▪ Additional research will be needed to replicate
the findings, develop Rx instructions in other
languages and comprehensively evaluate the pro-
posed instructions against the current standards.
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these instructions compared with a current standard, with
overall comprehension rates of the UMS instructions
exceeding 90%.11 Despite these findings and high levels of
support from government agencies, the UMS has not
been universally adopted by pharmacies and healthcare
organisations.
While the current UMS framework is a promising first
step towards promoting safe and appropriate medication
use, to date, it has only been applied to daily use, solid-
form medications. To address this shortcoming, our
team sought to apply UMS principles to instructions for:
(1) non-pill form (ie, injections, inhalers and liquids);
(2) short term (ie, antibiotics); (3) ‘as needed’ (ie, pain
relievers) and (4) tapered and escalating dose medica-
tions (ie, steroids and antidepressants). These medica-
tions account for a sizeable proportion of the short-term
and chronic care medications currently prescribed and
are often the most confusing and difficult for patients to
self-administer.2 12 To accomplish our objective, we first
developed a draft set of instructions incorporating
health literacy best practices with the assistance of a
Scientific Advisory Board (SAB). We then conducted an
iterative series of discussion groups with patients to




As the first step in the development process, the study
team drafted an initial set of ‘improved’ medication
instructions for non-pill form, short term, ‘as needed,’
tapered and escalating dose medications. Instructions
incorporated the UMS and health literacy best practices
whenever possible.10 The SAB, comprised three health
literacy and drug labelling experts (2 physicians, 1 psych-
ologist), assisted the study team in this process. Figure 1
provides an overview of key health literacy principles
and an explanation of how they were incorporated into
the design of the ‘improved’ draft instructions devel-
oped by the study team.
Study participants
To incorporate a patient’s perspective into the develop-
ment of improved instructions, a series of brief inter-
views and discussion groups were then conducted. Study
participants included adult patients who were recruited
via convenience sampling from clinics in Chicago,
Illinois and San Francisco, California, USA. Eligibility
criteria were purposively broad and included: (1) age 18
or older, (2) English-speaking, (3) taken at least one pre-
scription medication in the past year and (4) no severe
cognitive or visual impairment that would preclude their
informed consent or study participation. Study flyers
briefly described the research study and asked interested
individuals to call a research assistant (RA) to learn
more about the study. Trained RAs spoke to interested
participants by phone, assessed eligibility and scheduled
focus groups around participant availability. The
Institutional Review Boards (IRBs) of the University of
California at San Francisco and Northwestern University
approved the study.
Individual interviews
All participants completed a brief, individual interview
prior to the discussion group. The individual interview
was administered by RAs in a private area and included
assessments of the participant’s sociodemographics (age,
sex, education, income, insurance coverage, employ-
ment status) and health characteristics (health status,
prescription medication use, chronic health conditions).
Literacy skills were measured through the Rapid
Estimate of Adult Literacy in Medicine (REALM), a
short screening test designed to identify individuals with
reading difficulties.13
Discussion groups
Discussion groups were held immediately following the
individual interviews. A total of four focus groups were
conducted (n=2 in each location), each lasting approxi-
mately 1 h. All groups were moderated by two study
team members (SCB and MSW) to ensure consistency.
During these discussion groups, participants were shown
a series of ‘standard’ and ‘improved’ medication instruc-
tions for non-pill form, short term, ‘as needed,’ tapered
and escalating dose medications. For each type of medi-
cation, participants were asked to consider how the ter-
minology and phrasing of instructions could be
improved to promote comprehension. Discussions were
iterative in nature; suggestions made during initial focus
groups were reviewed in later discussion groups. The
study team refined the set of ‘improved’ instructions
Figure 1 Applying health
literacy practices to prescription
medication labelling.
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periodically based on discussion group feedback. The
study participants were compensated US$40 cash for
their time and effort.
Analysis plan
Quantitative analyses were performed using STATA,
V.11.0. Specifically, descriptive statistics were calculated
for variables measuring the participants’ sociodemo-
graphic and health characteristics. REALM scores were
dichotomised; participants were classified as having
either adequate or low/marginal literacy skills. A qualita-
tive descriptive approach was utilised for discussion
groups, which were recorded using a separate note-taker
at each session. Investigators utilised a content analysis
approach, where the patient comments and discussions
were broadly categorised and classified to discern partici-
pants’ preferences for optimal wording, phrasing and
content of medication instructions.14 15 Final wording
and phrasing choices were determined based on sugges-
tions that were endorsed by the majority of discussion
groups.
RESULTS
A total of 40 participants were enrolled in the study
across four discussion groups (n=20 per location).
Discussion groups were held from December 2012 to
April 2013; two discussion groups were conducted at
each of the study locations. Table 1 describes the socio-
demographic and health characteristics of the study
sample. Overall, participants varied greatly in terms of
their educational attainment, age and income. The
mean age of participants was 46 (range 21–67) and the
majority were female (60%) with low income. On an
average, participants took four prescription medications
and reported having two chronic health conditions.
Almost all participants (92.5%) had taken a non-pill
form, short term, as needed, escalating or tapered dose
medication in the previous year; half of them had used
three or more of these types of medications. One-third
of participants (33%) were classified as having inad-
equate literacy skills; according to REALM criteria, these
participants were reading on less than a 9th grade level.
The participants’ sociodemographic attributes, health
characteristics and literacy skills were similar between
the study locations.
Discussion group findings
Results from the discussion groups indicated that most
of the standard instructions could be enhanced to
promote patient’s understanding. Overall, participants
found most of the standard instructions to be unneces-
sarily confusing and complicated. One participant sum-
marised these feelings by stating: “You need medication
just to use the label.” The findings are displayed by topic
area below. Table 2 displays examples of standard
instructions and improved instructions developed based
on group discussions.
Use of terminology
Participants suggested using clear, concise wording and
phrasing whenever possible. Certain words, such as ‘sub-
cutaneously’ and ‘inhalation,’ were viewed as unneces-
sarily difficult, and often confusing, by many
participants. One participant in Chicago explained:
“When you read ‘subcutaneously’ you think, what in the
world are they talking about?” Potential alternatives were
discussed; most of the participants ultimately supported
using ‘under your skin’ and ‘puff ’, respectively.
Greater disagreement was expressed over measure-
ment terminology for liquid medications. Participants
were informed about standards supporting the use of
‘mL’ as a unit of measurement instead of ‘teaspoon’ or
‘teaspoonful’; these recommendations were developed
due to dosing errors that commonly occur when patients
or caregivers use household teaspoons, which are often
highly variable, to dose medications.16 17 Some partici-
pants believed that mL should be used on the label due
to these dosing concerns. One participant summarised
this point of view by stating: “If you don’t want us to use
a teaspoon, then don’t put that on the label.” In con-
trast, other participants were against using mL as it was
an unfamiliar term. One participant stated: “5mL? I
have no idea what that is.” There was concern that using
this unfamiliar term might lead to even greater dosing
errors. Some participants suggested using illustrations to
support the measurement of liquid medications. They
also emphasised the importance of always providing
patients or caregivers with the appropriate dosing instru-
ments (ie, cups, syringes) if an unfamiliar term like mL
was included on the Rx label.
Presentation of numbers
Consistent with health literacy best practices, improved
instructions contained numeric instead of alphanumeric
Table 1 Characteristics of study sample
Variable Participants (n=40)
Age, mean (SD) 45.9 (14.0)
Male (%) 40.0
Educational attainment (%)
Some high school 17.5











# Rx drugs taken, mean (SD) 4.13 (2.9)
# Chronic conditions, mean (SD) 1.93 (1.7)
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presentations of numbers (ie, 1 vs ‘one’). However, to
our knowledge, prior research has not examined how to
best present fractions on Rx labels. Fractions may be
common, particularly for medications requiring a
tapered or escalating dose. Participants were shown
various options for half a pill, including 0.5, 1/2, ½ and
the word ‘half.’ Participants overwhelmingly preferred
‘half,’ and believed that the fraction and decimal
options could cause greater confusion. One participant
explained this viewpoint by saying: “Half is universal, ½
could be too small and not everyone will be able to see
it.” When asked their preference for one and a half,
most participants preferred to have the entire phrase
written out as opposed to 1 ½, 1 1/2, 1.5 or 1 and a half
for similar reasons.
Understanding when medications should be taken
Two of the improved instructions included information
on when medication should be taken (ie, when you are
short of breath, if you have pain). Participants sup-
ported including this information at the beginning of
the instruction and removing the term ‘as needed’ to
avoid any confusion. Providing clear information on
when medications should be taken upfront helped
orient participants to the medication-taking process
and provided clear guidance on how to link symptoms
to the need to take medication. During these discus-
sions, participants also reported the need to describe
symptoms that would prompt medication use in the
clearest manner possible. For example, while most of
the participants understood the phrase ‘short of
breath,’ some questioned whether another phrase, such
as ‘difficulty breathing’ or ‘trouble breathing,’ should
be used instead. Others disliked these alternative
phrases as they felt having asthma necessarily meant
you had ‘trouble breathing,’ whereas ‘shortness of
breath’ occurred on isolated occasions. Overall, ‘short
of breath’ was endorsed by the majority of participants.
Timing and duration of use
Overall, participants supported the UMS framework and
tying medication use to specific time periods. When
Table 2 Standard and Improved Rx Instructions
Standard Improved
Non-pill Form
Take one inhalation twice daily Take 1 puff in the morning and
1 puff in the evening every day
Take two inhalations every 4–6 hours as needed When you are short of breath,
Take 2 puffs at a time.
Wait at least 4 hours.
If shortness of breath continues,
Take 2 more puffs.
Take 20 units subcutaneously once daily. Inject 20 units under your skin in the morning.
Take one teaspoonful (5 mL) three times daily. Take 5 mL in the morning,
5 mL in the evening, and
5 mL at bedtime.*
As Needed
Take 1–2 tablets every 4–6 hours as needed for pain.
Do not take more than 6 pills in 24 hours.
If you have pain,
Take 1 or 2 pills.
Wait at least 4 hours before taking again.
Do not take more than 6 pills in 24 hours.
Short Term
Take one tablet three times a day for 7 days. For 7 days:
Take 1 pill in the morning,
1 pill in the evening, and
1 pill at bedtime until all pills have been taken.
Escalating Dose
Take 1/2 tablet once a day for 7 days and then 1 tablet daily. For 7 days, take half a pill in the morning.
After 7 days, take 1 pill in the morning.
Tapered Dose
Take eight tablets once a day for three days,
six tablets once a day for three days,
four tablets once a day for three days,
three tablets once a day for three days,
two tablets once a day for three days,
one tablet once a day for three days.
External aids needed
*Should be accompanied by illustrations and appropriate dosing device
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medications required taking doses for a specific period
of time (ie, for 7 days), participants suggested placing
this information at the beginning of the instruction to
better orient patients. For short-term medications such
as antibiotics, participants suggested adding the phrase
‘until all pills have been taken’ to the end of the instruc-
tion. This phrase was preferred over other suggestions,
such as ‘until pills are gone’ or ‘until the bottle is
empty.’ For pain relievers with a maximum daily dosage,
participants approved of adding the statement ‘Do not
take more than 6 pills in 24 h.’ Many participants
believed there was a benefit to adding the word
‘warning’ or ‘caution’ before this phrase to highlight the
importance of the message; between these two terms,
‘warning’ was preferred by the majority of participants.
Overall, participants reported wanting very specific,
detailed information on how to take medication; discus-
sions also highlighted the need to choose optimal phras-
ing and wording to promote ease of understanding.
Need for external aids and counselling
While discussion groups were designed to focus on
improvements that could be made to Rx labels, partici-
pants frequently expressed a need for greater counsel-
ling and education to support safe medication use,
especially for challenging-to-use medications. This was
particularly the case for tapered dose medications (see
table 2). While the study team attempted to simplify
instructions for these drugs, participants strongly felt
that external aids and counselling were necessary to
properly educate patients on their use. When viewing
the length and complexity of written instructions for a
tapered dose medication, one participant commented:
“People will feel overwhelmed and get a headache if all
this information is on the label.” In terms of external
aids, participants thought that a calendar-based tool
would support safe and appropriate use; they also
approved of blister packs. Otherwise, as one participant
noted, “By the time you get to day 10, you don’t
remember what day you started the medicine.” Overall,
discussions highlighted the need to provide additional
support to patients to promote safe and consistent
medication use; improving labelling alone was seen as
an insufficient means of improving medication under-
standing and use.
General medication-related challenges
It is also important to note that certain key points arose
that were not specific to any of the proposed medication
instructions. Specifically, participants clearly and repeat-
edly stated the general and well-known difficulties of
consistently remembering to take chronic medications.
Moreover, participants expressed their dissatisfaction
with long wait times and brief interactions with physi-
cians and pharmacists. Participants routinely voiced
their opinion that “Everyone should have the right to
talk to the pharmacist” but noted that not all patients
were afforded that opportunity. Participants saw the lack
of communication between providers and patients as
barriers to understanding and using medications prop-
erly. These points mirrored other discussions on the
need to consider avenues beyond medication labelling
to promote safe and appropriate prescription drug use.
DISCUSSION
The instructions developed in this study are for some of
the most commonly used medications today, including
insulin, antibiotics, corticosteroids and antidepressants.18
Developing easy-to-understand instructions for these
medications is essential, as Rx labels are often the most
tangible, frequently used source of information for
patients on proper medication use.10 Our study findings
can help advance the science of optimising drug label-
ling practices from a patient’s perspective.
Our study was conducted among a group of partici-
pants from two distinct geographic locations; partici-
pants varied in terms of age, education and income. Yet,
there was a high level of agreement on how to best
phrase Rx instructions to promote comprehension.
Many health literacy best practices for drug labelling,
such as using simpler wording and explicit directions,
were readily supported by participants. This is consistent
with prior studies, including many conducted by
members of our research team.9 19 20 Some of the most
valuable, novel findings from the discussion groups were
related to presenting numerical information on Rx
labels, selecting measurement terminology for liquid
drugs and the need for external aids to support tapered
dosing. In terms of presenting fractions, participant
feedback suggested that writing out the fraction (ie, half
or one and a half) was superior to other formats (ie, ½,
1/2 or 0.5). In general, health literacy research suggests
that numeric presentations of numbers are superior to
alphanumeric; this finding is therefore unique and
somewhat in contrast to accepted health literacy prac-
tices.10 21 Regarding terminology for measuring liquid
medications, many participants were uncomfortable with
mL as a unit of measurement, mostly due to a lack of
familiarity with the term. This could be one underlying
root cause of misunderstanding of liquid medication
instructions; previous research has consistently shown
that patients have difficulty measuring liquid medica-
tions correctly.22 To further complicate the problem, evi-
dence also suggests that Rx instructions and
accompanying measurement devices (ie, syringes, cups)
often utilise different units of measurement, potentially
leading to greater confusion for the patients.23
Participant feedback suggests that if mL is used on Rx
labels, additional illustrations and accompanying meas-
urement devices with the same unit of measurement
would be necessary to promote safe and appropriate
dosing. Additional research will be needed to develop,
refine and test tools and counselling strategies to
support patient’s understanding and use of these
medications.
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Finally, the discussion groups underscored the neces-
sity of external aids and counselling for tapered dose
medications. Their comments about the unmet need for
medication counselling and barriers to medication com-
prehension at the pharmacy are consistent with previous
studies.24 25 This suggests that policy efforts, for
example, legislation requiring patient counselling at
pharmacies, have either not been implemented
adequately or have not necessarily led to improved
patient education.26 Continued efforts are needed to
promote patient counselling and support of medication
use; innovations in technology and more supportive
reimbursement policies may assist in this process.
By incorporating the UMS, health literacy principles
and patients’ perspectives, our team created a set of Rx
instructions that can be adopted by prescribers and
pharmacies to support patient’s understanding and use
of prescribed drugs. This expansion addresses one of
the major limitations of the UMS, making it a more uni-
versal, widely adoptable framework. While additional
barriers exist—such as the need to update labelling soft-
ware and to educate prescribers and pharmacists on the
importance of health literacy-informed labelling—we
believe our current efforts are an instrumental first step
towards promoting the adoption of the UMS. This is par-
ticularly timely and relevant, as the California State
Board of Pharmacy recently passed regulations requiring
pharmacies throughout the state to generate standar-
dised Rx labels that incorporate health literacy princi-
ples; regulations specifically referenced using the UMS
as a best practice.27 A number of other states are now
considering similar legislation. The Rx instructions
developed through this study can help support these
initiatives, promoting the adoption and use of patient-
centred drug labelling.
This study has limitations that should be noted. It
relies on a relatively small sample of English-speaking
adults. Additional research will be needed to replicate
findings and develop Rx instructions in other languages,
which we have carried out with chronic pill-form medi-
cations.28 While participants were recruited from two
geographically distinct locations, convenience sampling
was used, which may limit the generalisability of our
findings. Finally, this study focused on the development
of Rx instructions. Future comprehension testing is
planned to evaluate the proposed Rx instructions
against standard instructions using hypothetical medica-
tions. If instructions are found to promote understand-
ing, an actual use assessment would be necessary to
demonstrate the efficacy.
In conclusion, through this project, our team devel-
oped a set of patient-centred, health-literacy informed
Rx instructions for use with non-pill form, short term, as
needed, tapered and escalating dose medications. These
Rx instructions are an essential next step to promoting
comprehensive patient-centred labelling in the USA. Given
the building evidence in support of the UMS framework,
the California State Board of Pharmacy recommended its
use to pharmacy practices to fulfil recent regulations pro-
moting patient-centred labelling.27 Others are now consid-
ering similar requirements and efforts have been launched
across a number of states to advocate for improved Rx
labelling. If found to support comprehension, our Rx
instructions could provide valuable guidance to legislators,
regulatory agencies, prescribers and pharmacists on how to
label non-pill form, as needed, short term, tapered and
escalating dose medications.
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